메뉴 건너뛰기




Volumn 110, Issue 2, 2006, Pages 296-306

Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting

Author keywords

Atomic force microscopy; Epidermal targeting; High pressure homogenization; Photon correlation spectroscopy; Podophyllotoxin; Solid lipid nanoparticles

Indexed keywords

ATOMIC FORCE MICROSCOPY; DRUG THERAPY; FLUORESCENCE; MEDICAL IMAGING; NANOSTRUCTURED MATERIALS; SKIN; X RAY DIFFRACTION ANALYSIS;

EID: 29244436380     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.09.052     Document Type: Article
Times cited : (302)

References (35)
  • 1
    • 0038032150 scopus 로고    scopus 로고
    • Solid lipid nanoparticles (SLN) for controlled drug delivery-review of the state of the art
    • R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery-review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
    • (2000) Eur. J. Pharm. Biopharm. , vol.50 , pp. 161-177
    • Müller, R.H.1    Mäder, K.2    Gohla, S.3
  • 2
    • 0035946615 scopus 로고    scopus 로고
    • Solid lipid nanoparticles: Production, characterization and applications
    • W. Mehnert, and K. Mäder Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196
    • (2001) Adv. Drug Deliv. Rev. , vol.47 , pp. 165-196
    • Mehnert, W.1    Mäder, K.2
  • 3
    • 0037453177 scopus 로고    scopus 로고
    • Cosmetic applications for solid lipid nanoparticles (SLN)
    • S.A. Wissing, and R.H. Müller Cosmetic applications for solid lipid nanoparticles (SLN) Int. J. Pharm. 254 2003 65 68
    • (2003) Int. J. Pharm. , vol.254 , pp. 65-68
    • Wissing, S.A.1    Müller, R.H.2
  • 4
    • 2242472082 scopus 로고    scopus 로고
    • Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations
    • R.H. Müller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 2002 S131 S155 (Suppl)
    • (2002) Adv. Drug Deliv. Rev. , vol.54
    • Müller, R.H.1    Radtke, M.2    Wissing, S.A.3
  • 6
    • 0035109447 scopus 로고    scopus 로고
    • Encapsulation of retinoids in solid lipid nanoparticles (SLN)
    • V. Jenning, and S. Gohla Encapsulation of retinoids in solid lipid nanoparticles (SLN) J. Microencapsul. 18 2001 149 158
    • (2001) J. Microencapsul. , vol.18 , pp. 149-158
    • Jenning, V.1    Gohla, S.2
  • 7
    • 0001889786 scopus 로고    scopus 로고
    • The next generation after the liposomes: Solid lipid nanoparticles (SLN ™, Lipopearls ™) as dermal carrier in cosmetics
    • R.H. Müller, and A. Dingler The next generation after the liposomes: solid lipid nanoparticles (SLN ™, Lipopearls ™) as dermal carrier in cosmetics Eurocosmetics 7/8 1998 19 26
    • (1998) Eurocosmetics , vol.7-8 , pp. 19-26
    • Müller, R.H.1    Dingler, A.2
  • 8
    • 0034595218 scopus 로고    scopus 로고
    • Vitamin a loaded solid lipid nanoparticles for topical use: Occlusive properties and drug targeting to the upper skin
    • V. Jenning, A. Gysler, M. Schäfer-Korting, and S.H. Gohla Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin Eur. J. Pharm. Biopharm. 49 2000 211 218
    • (2000) Eur. J. Pharm. Biopharm. , vol.49 , pp. 211-218
    • Jenning, V.1    Gysler, A.2    Schäfer-Korting, M.3    Gohla, S.H.4
  • 9
    • 0037677618 scopus 로고    scopus 로고
    • The influence of solid lipid nanoparticles on skin hydration and viscoelasticity-in vivo study
    • S.A. Wissing, and R.H. Müller The influence of solid lipid nanoparticles on skin hydration and viscoelasticity-in vivo study Eur. J. Pharm. Biopharm. 56 2003 67 72
    • (2003) Eur. J. Pharm. Biopharm. , vol.56 , pp. 67-72
    • Wissing, S.A.1    Müller, R.H.2
  • 10
    • 17344391922 scopus 로고    scopus 로고
    • Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties
    • V. Jenning, M. Schäfer-Korting, and S.H. Gohla Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties J. Control. Release 66 2000 115 126
    • (2000) J. Control. Release , vol.66 , pp. 115-126
    • Jenning, V.1    Schäfer-Korting, M.2    Gohla, S.H.3
  • 11
    • 0031960962 scopus 로고    scopus 로고
    • Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism
    • A. zur Mühlen, C. Schwarz, and W. Mehnert Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism Eur. J. Pharm. Biopharm. 45 1998 149 155
    • (1998) Eur. J. Pharm. Biopharm. , vol.45 , pp. 149-155
    • Zur Mühlen, A.1    Schwarz, C.2    Mehnert, W.3
  • 12
    • 0037124539 scopus 로고    scopus 로고
    • Solid lipid nanoparticles as carrier for sunscreens: In vitro release and in vivo skin penetration
    • S.A. Wissing, and R.H. Müller Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration J. Control. Release 81 2002 225 233
    • (2002) J. Control. Release , vol.81 , pp. 225-233
    • Wissing, S.A.1    Müller, R.H.2
  • 13
    • 0033976172 scopus 로고    scopus 로고
    • Solid lipid nanoparticles as drug carriers for topical glucocorticoids
    • C.S. Maia, W. Mehnert, and M. Schäfer-Korting Solid lipid nanoparticles as drug carriers for topical glucocorticoids Int. J. Pharm. 196 2000 165 167
    • (2000) Int. J. Pharm. , vol.196 , pp. 165-167
    • Maia, C.S.1    Mehnert, W.2    Schäfer-Korting, M.3
  • 15
    • 2442712381 scopus 로고    scopus 로고
    • Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery
    • E.B. Souto, S.A. Wissing, C.M. Barbosa, and R.H. Müller Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery Int. J. Pharm. 278 2004 71 77
    • (2004) Int. J. Pharm. , vol.278 , pp. 71-77
    • Souto, E.B.1    Wissing, S.A.2    Barbosa, C.M.3    Müller, R.H.4
  • 16
    • 0034997053 scopus 로고    scopus 로고
    • Condyloma eradication: Self-therapy with 0.15-0.5% podophyllotoxin versus 20-25% podophyllin preparations-an integrated safety assessment
    • E. Longstaff, and G. von Krogh Condyloma eradication: self-therapy with 0.15-0.5% podophyllotoxin versus 20-25% podophyllin preparations-an integrated safety assessment Regul. Toxicol. Pharmacol. 33 2001 117 137
    • (2001) Regul. Toxicol. Pharmacol. , vol.33 , pp. 117-137
    • Longstaff, E.1    Von Krogh, G.2
  • 17
    • 0032033637 scopus 로고    scopus 로고
    • Discovery of podophyllotoxins
    • T.F. Imbert Discovery of podophyllotoxins Biochimie 80 1998 207 222
    • (1998) Biochimie , vol.80 , pp. 207-222
    • Imbert, T.F.1
  • 19
    • 0028011910 scopus 로고
    • Characterization of diazepam submicron emulsion interface: Role of oleic acid
    • M.Y. Levy, W. Schutze, C. Fuhrer, and S. Benita Characterization of diazepam submicron emulsion interface: role of oleic acid J. Microencapsul. 11 1994 79 92
    • (1994) J. Microencapsul. , vol.11 , pp. 79-92
    • Levy, M.Y.1    Schutze, W.2    Fuhrer, C.3    Benita, S.4
  • 20
    • 0037422347 scopus 로고    scopus 로고
    • Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): A detailed study of preparation and stability parameters
    • P. Shahgaldian, E.D. Silva, A.W. Coleman, B. Rather, and M.J. Zaworotko Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters Int. J. Pharm. 253 2003 23 38
    • (2003) Int. J. Pharm. , vol.253 , pp. 23-38
    • Shahgaldian, P.1    Silva, E.D.2    Coleman, A.W.3    Rather, B.4    Zaworotko, M.J.5
  • 21
    • 0037723990 scopus 로고    scopus 로고
    • Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins
    • A. Dubes, H. Parrot-Lopez, W. Abdelwahed, G. Degobert, H. Fessi, P. Shahgaldian, and A.W. Coleman Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins Eur. J. Pharm. Biopharm. 55 2003 279 282
    • (2003) Eur. J. Pharm. Biopharm. , vol.55 , pp. 279-282
    • Dubes, A.1    Parrot-Lopez, H.2    Abdelwahed, W.3    Degobert, G.4    Fessi, H.5    Shahgaldian, P.6    Coleman, A.W.7
  • 22
    • 0036250178 scopus 로고    scopus 로고
    • Preparation and characterization of solid lipid nanoparticles
    • S.C. Yang, and J.B. Zhu Preparation and characterization of solid lipid nanoparticles Drug Dev. Ind. Pharm. 28 2002 265 274
    • (2002) Drug Dev. Ind. Pharm. , vol.28 , pp. 265-274
    • Yang, S.C.1    Zhu, J.B.2
  • 23
    • 1542611547 scopus 로고    scopus 로고
    • Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles
    • V. Venkateswarlu, and K. Manjunath Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles J. Control. Release 95 2004 627 638
    • (2004) J. Control. Release , vol.95 , pp. 627-638
    • Venkateswarlu, V.1    Manjunath, K.2
  • 24
    • 0005232487 scopus 로고
    • Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol
    • B. Seikmann, and K. Westesen Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol Pharm. Pharmacol. Lett. 3 1994 225 228
    • (1994) Pharm. Pharmacol. Lett. , vol.3 , pp. 225-228
    • Seikmann, B.1    Westesen, K.2
  • 25
    • 0037404980 scopus 로고    scopus 로고
    • The production and characteristics of solid lipid nanoparticles (SLNs)
    • D. Hou, C. Xie, K. Huang, and C. Zhu The production and characteristics of solid lipid nanoparticles (SLNs) Biomaterials 24 2003 1781 1785
    • (2003) Biomaterials , vol.24 , pp. 1781-1785
    • Hou, D.1    Xie, C.2    Huang, K.3    Zhu, C.4
  • 26
    • 0345390953 scopus 로고    scopus 로고
    • Correlation between long-term stability of solid lipid nanoparticles (SLN ™) and crystallinity of the lipid phase
    • C. Freitas, and R.H. Müller Correlation between long-term stability of solid lipid nanoparticles (SLN ™) and crystallinity of the lipid phase Eur. J. Pharm. Biopharm. 47 1999 125 132
    • (1999) Eur. J. Pharm. Biopharm. , vol.47 , pp. 125-132
    • Freitas, C.1    Müller, R.H.2
  • 27
    • 0037449516 scopus 로고    scopus 로고
    • Influence of ion pairing on topical delivery of retinoic acid from microemulsions
    • M. Trotta, E. Ugazio, E. Peira, and C. Pulitano Influence of ion pairing on topical delivery of retinoic acid from microemulsions J. Control. Release 86 2003 315 321
    • (2003) J. Control. Release , vol.86 , pp. 315-321
    • Trotta, M.1    Ugazio, E.2    Peira, E.3    Pulitano, C.4
  • 28
    • 0035465206 scopus 로고    scopus 로고
    • Investigations on the occlusive properties of solid lipid nanoparticles (SLN)
    • S.A. Wissing, A. Lippacher, and R.H. Müller Investigations on the occlusive properties of solid lipid nanoparticles (SLN) J. Cosmet. Sci. 52 2001 313 323
    • (2001) J. Cosmet. Sci. , vol.52 , pp. 313-323
    • Wissing, S.A.1    Lippacher, A.2    Müller, R.H.3
  • 30
    • 0035965486 scopus 로고    scopus 로고
    • Interaction of liposome formulations with human skin in vitro
    • G. Betz, R. Imboden, and G. Imanidis Interaction of liposome formulations with human skin in vitro Int. J. Pharm. 229 2001 117 129
    • (2001) Int. J. Pharm. , vol.229 , pp. 117-129
    • Betz, G.1    Imboden, R.2    Imanidis, G.3
  • 32
    • 1542268930 scopus 로고    scopus 로고
    • Lipid vesicles and other colloids as drug carriers on the skin
    • G. Cevc Lipid vesicles and other colloids as drug carriers on the skin Adv. Drug Deliv. Rev. 56 2004 675 717
    • (2004) Adv. Drug Deliv. Rev. , vol.56 , pp. 675-717
    • Cevc, G.1
  • 35
    • 0345761185 scopus 로고    scopus 로고
    • Deformable liposomes for dermal administration of methotrexate
    • M. Trotta, E. Peira, M.E. Carlotti, and M. Gallarate Deformable liposomes for dermal administration of methotrexate Int. J. Pharm. 270 2004 119 125
    • (2004) Int. J. Pharm. , vol.270 , pp. 119-125
    • Trotta, M.1    Peira, E.2    Carlotti, M.E.3    Gallarate, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.